GLycaemic Outcomes With Whey Protein in ageING
Eligible age
70–90 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this placebo-controlled, partial crossover design study is to identify the impact of consuming whey protein before meals on free-living glucose control in older adults living with type 2 diabetes. The primary specific objective is to determine the effect of a thrice daily whey protein pre-meal supplementation at two doses, on glucose excursions over a 7-day free-living period in adults aged 70-90 years of age, living with type 2 diabetes, compared with a non-protein placebo. Participants will consume the whey protein and placebo for 7 days each, before each meal. All participants will consume the placebo and one of two doses of whey protein, in a randomised order.
Sponsor: University of Birmingham
You may not qualify if…
- ✕ \<70 years old and over 90 years of age
- ✕ Currently on fast-acting insulin therapy (i.e., Humalog)
- ✕ Confirmed uncontrolled diabetes (HbA1C \>10% or 85mmol/mol).
- ✕ Currently on GLP-1 therapy
- ✕ Habitual smoker or vaper
- ✕ Veganism
- ✕ Lactose or dairy intolerance
- ✕ Coeliac or gluten intolerance
Source: ClinicalTrials.gov · NCT07285811 · last updated 2026-08-18